Covid-19 Impact on Global Cough and Cold Preparations Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 28-May-2020
No. of pages: 153
Inquire Before Buying

Cough and Cold Preparations market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cough and Cold Preparations market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cough and Cold Preparations market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Cough and Cold Preparations industry.

The key players covered in this study

  • GlaxoSmithKline

  • AstraZeneca

  • Bayer

  • Blackmores Limited

  • Dabur

  • Johnson & Johnson

  • Reckitt Benckiser

  • Pfizer

  • Sun Pharmaceutical

  • Novartis

  • Prestige Brands

  • Procter & Gamble

  • Toray Industries

  • Beijing Tongrentang

  • Essence Pharmaceutical Group

  • Jiangxi Heying Pharmaceutical

  • Diao Group Chengdu Pharmaceutical

  • Shanghai Pharmaceutical

  • Harbin Children's Pharmaceutical

  • China Resources Sanjiu Pharmaceutical

  • Xinjiang Quanan Pharmaceutical

  • Jiangsu Huayang Pharmaceutical

  • Nanjing Chengong Pharmaceutical

  • Beijing Jiulong Pharmaceutical

  • Livzon Group

  • Sinopharm Group

  • CSPC

  • Perrigo Company

  • Vernalis

  • Tris Pharma

  • Acella Pharmaceuticals

Market segment by Type, the product can be split into

  • by Dosage Type

  • Tablet

  • Solution

  • Drops

  • Capsule

  • Granules

  • Syrup

  • Pills

  • by Drug Type

  • Antihistamines

  • Expectorants

  • Bronchodilators

  • Decongestants

  • Antibiotics

  • Others

Market segment by Application, split into

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Drug Stores

  • Supermarkets/Hypermarkets

  • Others

Market segment by Regions/Countries, this report covers

  • North America

  • Europe

  • China

  • Japan

  • Southeast Asia

  • India

  • Central & South America

The study objectives of this report are:

  • To analyze global Cough and Cold Preparations status, future forecast, growth opportunity, key market and key players.

  • To present the Cough and Cold Preparations development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

  • To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cough and Cold Preparations are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Covid-19 Impact on Global Cough and Cold Preparations Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cough and Cold Preparations Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Cough and Cold Preparations Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tablet
1.4.3 Solution
1.4.4 Drops
1.4.5 Capsule
1.4.6 Granules
1.4.7 Syrup
1.4.8 Pills
1.5 Market by Application
1.5.1 Global Cough and Cold Preparations Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Drug Stores
1.5.5 Supermarkets/Hypermarkets
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cough and Cold Preparations Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Covid-19 Implications on Global Cough and Cold Preparations Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Cough and Cold Preparations Growth Trends by Regions
2.2.1 Cough and Cold Preparations Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cough and Cold Preparations Historic Market Share by Regions (2015-2020)
2.2.3 Cough and Cold Preparations Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Cough and Cold Preparations Market Growth Strategy
2.3.6 Primary Interviews with Key Cough and Cold Preparations Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Cough and Cold Preparations Players by Market Size
3.1.1 Global Top Cough and Cold Preparations Players by Revenue (2015-2020)
3.1.2 Global Cough and Cold Preparations Revenue Market Share by Players (2015-2020)
3.1.3 Global Cough and Cold Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cough and Cold Preparations Market Concentration Ratio
3.2.1 Global Cough and Cold Preparations Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cough and Cold Preparations Revenue in 2019
3.3 Cough and Cold Preparations Key Players Head office and Area Served
3.4 Key Players Cough and Cold Preparations Product Solution and Service
3.5 Date of Enter into Cough and Cold Preparations Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global Cough and Cold Preparations Historic Market Size by Type (2015-2020)
4.2 Global Cough and Cold Preparations Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Cough and Cold Preparations Market Size by Application (2015-2020)
5.2 Global Cough and Cold Preparations Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
6.1 North America Cough and Cold Preparations Market Size (2015-2020)
6.2 Cough and Cold Preparations Key Players in North America (2019-2020)
6.3 North America Cough and Cold Preparations Market Size by Type (2015-2020)
6.4 North America Cough and Cold Preparations Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
7.1 Europe Cough and Cold Preparations Market Size (2015-2020)
7.2 Cough and Cold Preparations Key Players in Europe (2019-2020)
7.3 Europe Cough and Cold Preparations Market Size by Type (2015-2020)
7.4 Europe Cough and Cold Preparations Market Size by Application (2015-2020)
8 China Impact of COVID-19
8.1 China Cough and Cold Preparations Market Size (2015-2020)
8.2 Cough and Cold Preparations Key Players in China (2019-2020)
8.3 China Cough and Cold Preparations Market Size by Type (2015-2020)
8.4 China Cough and Cold Preparations Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
9.1 Japan Cough and Cold Preparations Market Size (2015-2020)
9.2 Cough and Cold Preparations Key Players in Japan (2019-2020)
9.3 Japan Cough and Cold Preparations Market Size by Type (2015-2020)
9.4 Japan Cough and Cold Preparations Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
10.1 Southeast Asia Cough and Cold Preparations Market Size (2015-2020)
10.2 Cough and Cold Preparations Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cough and Cold Preparations Market Size by Type (2015-2020)
10.4 Southeast Asia Cough and Cold Preparations Market Size by Application (2015-2020)
11 India Impact of COVID-19
11.1 India Cough and Cold Preparations Market Size (2015-2020)
11.2 Cough and Cold Preparations Key Players in India (2019-2020)
11.3 India Cough and Cold Preparations Market Size by Type (2015-2020)
11.4 India Cough and Cold Preparations Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
12.1 Central & South America Cough and Cold Preparations Market Size (2015-2020)
12.2 Cough and Cold Preparations Key Players in Central & South America (2019-2020)
12.3 Central & South America Cough and Cold Preparations Market Size by Type (2015-2020)
12.4 Central & South America Cough and Cold Preparations Market Size by Application (2015-2020)
13Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline Cough and Cold Preparations Introduction
13.1.4 GlaxoSmithKline Revenue in Cough and Cold Preparations Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca Cough and Cold Preparations Introduction
13.2.4 AstraZeneca Revenue in Cough and Cold Preparations Business (2015-2020)
13.2.5 AstraZeneca Recent Development and Reaction to COVID-19
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview and Its Total Revenue
13.3.3 Bayer Cough and Cold Preparations Introduction
13.3.4 Bayer Revenue in Cough and Cold Preparations Business (2015-2020)
13.3.5 Bayer Recent Development and Reaction to COVID-19
13.4 Blackmores Limited
13.4.1 Blackmores Limited Company Details
13.4.2 Blackmores Limited Business Overview and Its Total Revenue
13.4.3 Blackmores Limited Cough and Cold Preparations Introduction
13.4.4 Blackmores Limited Revenue in Cough and Cold Preparations Business (2015-2020)
13.4.5 Blackmores Limited Recent Development and Reaction to COVID-19
13.5 Dabur
13.5.1 Dabur Company Details
13.5.2 Dabur Business Overview and Its Total Revenue
13.5.3 Dabur Cough and Cold Preparations Introduction
13.5.4 Dabur Revenue in Cough and Cold Preparations Business (2015-2020)
13.5.5 Dabur Recent Development and Reaction to COVID-19
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
13.6.3 Johnson & Johnson Cough and Cold Preparations Introduction
13.6.4 Johnson & Johnson Revenue in Cough and Cold Preparations Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development and Reaction to COVID-19
13.7 Reckitt Benckiser
13.7.1 Reckitt Benckiser Company Details
13.7.2 Reckitt Benckiser Business Overview and Its Total Revenue
13.7.3 Reckitt Benckiser Cough and Cold Preparations Introduction
13.7.4 Reckitt Benckiser Revenue in Cough and Cold Preparations Business (2015-2020)
13.7.5 Reckitt Benckiser Recent Development and Reaction to COVID-19
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview and Its Total Revenue
13.8.3 Pfizer Cough and Cold Preparations Introduction
13.8.4 Pfizer Revenue in Cough and Cold Preparations Business (2015-2020)
13.8.5 Pfizer Recent Development and Reaction to COVID-19
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Details
13.9.2 Sun Pharmaceutical Business Overview and Its Total Revenue
13.9.3 Sun Pharmaceutical Cough and Cold Preparations Introduction
13.9.4 Sun Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
13.9.5 Sun Pharmaceutical Recent Development and Reaction to COVID-19
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview and Its Total Revenue
13.10.3 Novartis Cough and Cold Preparations Introduction
13.10.4 Novartis Revenue in Cough and Cold Preparations Business (2015-2020)
13.10.5 Novartis Recent Development and Reaction to COVID-19
13.11 Prestige Brands
10.11.1 Prestige Brands Company Details
10.11.2 Prestige Brands Business Overview and Its Total Revenue
10.11.3 Prestige Brands Cough and Cold Preparations Introduction
10.11.4 Prestige Brands Revenue in Cough and Cold Preparations Business (2015-2020)
10.11.5 Prestige Brands Recent Development and Reaction to COVID-19
13.12 Procter & Gamble
10.12.1 Procter & Gamble Company Details
10.12.2 Procter & Gamble Business Overview and Its Total Revenue
10.12.3 Procter & Gamble Cough and Cold Preparations Introduction
10.12.4 Procter & Gamble Revenue in Cough and Cold Preparations Business (2015-2020)
10.12.5 Procter & Gamble Recent Development and Reaction to COVID-19
13.13 Toray Industries
10.13.1 Toray Industries Company Details
10.13.2 Toray Industries Business Overview and Its Total Revenue
10.13.3 Toray Industries Cough and Cold Preparations Introduction
10.13.4 Toray Industries Revenue in Cough and Cold Preparations Business (2015-2020)
10.13.5 Toray Industries Recent Development and Reaction to COVID-19
13.14 Beijing Tongrentang
10.14.1 Beijing Tongrentang Company Details
10.14.2 Beijing Tongrentang Business Overview and Its Total Revenue
10.14.3 Beijing Tongrentang Cough and Cold Preparations Introduction
10.14.4 Beijing Tongrentang Revenue in Cough and Cold Preparations Business (2015-2020)
10.14.5 Beijing Tongrentang Recent Development and Reaction to COVID-19
13.15 Essence Pharmaceutical Group
10.15.1 Essence Pharmaceutical Group Company Details
10.15.2 Essence Pharmaceutical Group Business Overview and Its Total Revenue
10.15.3 Essence Pharmaceutical Group Cough and Cold Preparations Introduction
10.15.4 Essence Pharmaceutical Group Revenue in Cough and Cold Preparations Business (2015-2020)
10.15.5 Essence Pharmaceutical Group Recent Development and Reaction to COVID-19
13.16 Jiangxi Heying Pharmaceutical
10.16.1 Jiangxi Heying Pharmaceutical Company Details
10.16.2 Jiangxi Heying Pharmaceutical Business Overview and Its Total Revenue
10.16.3 Jiangxi Heying Pharmaceutical Cough and Cold Preparations Introduction
10.16.4 Jiangxi Heying Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.16.5 Jiangxi Heying Pharmaceutical Recent Development and Reaction to COVID-19
13.17 Diao Group Chengdu Pharmaceutical
10.17.1 Diao Group Chengdu Pharmaceutical Company Details
10.17.2 Diao Group Chengdu Pharmaceutical Business Overview and Its Total Revenue
10.17.3 Diao Group Chengdu Pharmaceutical Cough and Cold Preparations Introduction
10.17.4 Diao Group Chengdu Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.17.5 Diao Group Chengdu Pharmaceutical Recent Development and Reaction to COVID-19
13.18 Shanghai Pharmaceutical
10.18.1 Shanghai Pharmaceutical Company Details
10.18.2 Shanghai Pharmaceutical Business Overview and Its Total Revenue
10.18.3 Shanghai Pharmaceutical Cough and Cold Preparations Introduction
10.18.4 Shanghai Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.18.5 Shanghai Pharmaceutical Recent Development and Reaction to COVID-19
13.19 Harbin Children's Pharmaceutical
10.19.1 Harbin Children's Pharmaceutical Company Details
10.19.2 Harbin Children's Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Harbin Children's Pharmaceutical Cough and Cold Preparations Introduction
10.19.4 Harbin Children's Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.19.5 Harbin Children's Pharmaceutical Recent Development and Reaction to COVID-19
13.20 China Resources Sanjiu Pharmaceutical
10.20.1 China Resources Sanjiu Pharmaceutical Company Details
10.20.2 China Resources Sanjiu Pharmaceutical Business Overview and Its Total Revenue
10.20.3 China Resources Sanjiu Pharmaceutical Cough and Cold Preparations Introduction
10.20.4 China Resources Sanjiu Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.20.5 China Resources Sanjiu Pharmaceutical Recent Development and Reaction to COVID-19
13.21 Xinjiang Quanan Pharmaceutical
10.21.1 Xinjiang Quanan Pharmaceutical Company Details
10.21.2 Xinjiang Quanan Pharmaceutical Business Overview and Its Total Revenue
10.21.3 Xinjiang Quanan Pharmaceutical Cough and Cold Preparations Introduction
10.21.4 Xinjiang Quanan Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.21.5 Xinjiang Quanan Pharmaceutical Recent Development and Reaction to COVID-19
13.22 Jiangsu Huayang Pharmaceutical
10.22.1 Jiangsu Huayang Pharmaceutical Company Details
10.22.2 Jiangsu Huayang Pharmaceutical Business Overview and Its Total Revenue
10.22.3 Jiangsu Huayang Pharmaceutical Cough and Cold Preparations Introduction
10.22.4 Jiangsu Huayang Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.22.5 Jiangsu Huayang Pharmaceutical Recent Development and Reaction to COVID-19
13.23 Nanjing Chengong Pharmaceutical
10.23.1 Nanjing Chengong Pharmaceutical Company Details
10.23.2 Nanjing Chengong Pharmaceutical Business Overview and Its Total Revenue
10.23.3 Nanjing Chengong Pharmaceutical Cough and Cold Preparations Introduction
10.23.4 Nanjing Chengong Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.23.5 Nanjing Chengong Pharmaceutical Recent Development and Reaction to COVID-19
13.24 Beijing Jiulong Pharmaceutical
10.24.1 Beijing Jiulong Pharmaceutical Company Details
10.24.2 Beijing Jiulong Pharmaceutical Business Overview and Its Total Revenue
10.24.3 Beijing Jiulong Pharmaceutical Cough and Cold Preparations Introduction
10.24.4 Beijing Jiulong Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020)
10.24.5 Beijing Jiulong Pharmaceutical Recent Development and Reaction to COVID-19
13.25 Livzon Group
10.25.1 Livzon Group Company Details
10.25.2 Livzon Group Business Overview and Its Total Revenue
10.25.3 Livzon Group Cough and Cold Preparations Introduction
10.25.4 Livzon Group Revenue in Cough and Cold Preparations Business (2015-2020)
10.25.5 Livzon Group Recent Development and Reaction to COVID-19
13.26 Sinopharm Group
10.26.1 Sinopharm Group Company Details
10.26.2 Sinopharm Group Business Overview and Its Total Revenue
10.26.3 Sinopharm Group Cough and Cold Preparations Introduction
10.26.4 Sinopharm Group Revenue in Cough and Cold Preparations Business (2015-2020)
10.26.5 Sinopharm Group Recent Development and Reaction to COVID-19
13.27 CSPC
10.27.1 CSPC Company Details
10.27.2 CSPC Business Overview and Its Total Revenue
10.27.3 CSPC Cough and Cold Preparations Introduction
10.27.4 CSPC Revenue in Cough and Cold Preparations Business (2015-2020)
10.27.5 CSPC Recent Development and Reaction to COVID-19
13.28 Perrigo Company
10.28.1 Perrigo Company Company Details
10.28.2 Perrigo Company Business Overview and Its Total Revenue
10.28.3 Perrigo Company Cough and Cold Preparations Introduction
10.28.4 Perrigo Company Revenue in Cough and Cold Preparations Business (2015-2020)
10.28.5 Perrigo Company Recent Development and Reaction to COVID-19
13.29 Vernalis
10.29.1 Vernalis Company Details
10.29.2 Vernalis Business Overview and Its Total Revenue
10.29.3 Vernalis Cough and Cold Preparations Introduction
10.29.4 Vernalis Revenue in Cough and Cold Preparations Business (2015-2020)
10.29.5 Vernalis Recent Development and Reaction to COVID-19
13.30 Tris Pharma
10.30.1 Tris Pharma Company Details
10.30.2 Tris Pharma Business Overview and Its Total Revenue
10.30.3 Tris Pharma Cough and Cold Preparations Introduction
10.30.4 Tris Pharma Revenue in Cough and Cold Preparations Business (2015-2020)
10.30.5 Tris Pharma Recent Development and Reaction to COVID-19
13.31 Acella Pharmaceuticals
10.31.1 Acella Pharmaceuticals Company Details
10.31.2 Acella Pharmaceuticals Business Overview and Its Total Revenue
10.31.3 Acella Pharmaceuticals Cough and Cold Preparations Introduction
10.31.4 Acella Pharmaceuticals Revenue in Cough and Cold Preparations Business (2015-2020)
10.31.5 Acella Pharmaceuticals Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Cough and Cold Preparations Key Market Segments
Table 2. Key Players Covered: Ranking by Cough and Cold Preparations Revenue
Table 3. Ranking of Global Top Cough and Cold Preparations Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cough and Cold Preparations Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Solution
Table 7. Key Players of Drops
Table 8. Key Players of Capsule
Table 9. Key Players of Granules
Table 10. Key Players of Syrup
Table 11. Key Players of Pills
Table 12. COVID-19 Impact Global Market: (Four Cough and Cold Preparations Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Cough and Cold Preparations Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Cough and Cold Preparations Players to Combat Covid-19 Impact
Table 17. Global Cough and Cold Preparations Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Cough and Cold Preparations Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Cough and Cold Preparations Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Cough and Cold Preparations Market Share by Regions (2015-2020)
Table 21. Global Cough and Cold Preparations Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Cough and Cold Preparations Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Cough and Cold Preparations Market Growth Strategy
Table 27. Main Points Interviewed from Key Cough and Cold Preparations Players
Table 28. Global Cough and Cold Preparations Revenue by Players (2015-2020) (Million US$)
Table 29. Global Cough and Cold Preparations Market Share by Players (2015-2020)
Table 30. Global Top Cough and Cold Preparations Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cough and Cold Preparations as of 2019)
Table 31. Global Cough and Cold Preparations by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Cough and Cold Preparations Product Solution and Service
Table 34. Date of Enter into Cough and Cold Preparations Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 37. Global Cough and Cold Preparations Market Size Share by Type (2015-2020)
Table 38. Global Cough and Cold Preparations Revenue Market Share by Type (2021-2026)
Table 39. Global Cough and Cold Preparations Market Size Share by Application (2015-2020)
Table 40. Global Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 41. Global Cough and Cold Preparations Market Size Share by Application (2021-2026)
Table 42. North America Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 44. North America Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 45. North America Cough and Cold Preparations Market Share by Type (2015-2020)
Table 46. North America Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 47. North America Cough and Cold Preparations Market Share by Application (2015-2020)
Table 48. Europe Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 50. Europe Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Cough and Cold Preparations Market Share by Type (2015-2020)
Table 52. Europe Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Cough and Cold Preparations Market Share by Application (2015-2020)
Table 54. China Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 55. China Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 56. China Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 57. China Cough and Cold Preparations Market Share by Type (2015-2020)
Table 58. China Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 59. China Cough and Cold Preparations Market Share by Application (2015-2020)
Table 60. Japan Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 62. Japan Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Cough and Cold Preparations Market Share by Type (2015-2020)
Table 64. Japan Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Cough and Cold Preparations Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 68. Southeast Asia Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Cough and Cold Preparations Market Share by Type (2015-2020)
Table 70. Southeast Asia Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Cough and Cold Preparations Market Share by Application (2015-2020)
Table 72. India Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 73. India Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 74. India Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 75. India Cough and Cold Preparations Market Share by Type (2015-2020)
Table 76. India Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 77. India Cough and Cold Preparations Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Cough and Cold Preparations Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Cough and Cold Preparations Market Share (2019-2020)
Table 80. Central & South America Cough and Cold Preparations Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Cough and Cold Preparations Market Share by Type (2015-2020)
Table 82. Central & South America Cough and Cold Preparations Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Cough and Cold Preparations Market Share by Application (2015-2020)
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Product
Table 92. AstraZeneca Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 93. AstraZeneca Recent Development
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Product
Table 97. Bayer Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 98. Bayer Recent Development
Table 99. Blackmores Limited Company Details
Table 100. Blackmores Limited Business Overview
Table 101. Blackmores Limited Product
Table 102. Blackmores Limited Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 103. Blackmores Limited Recent Development
Table 104. Dabur Company Details
Table 105. Dabur Business Overview
Table 106. Dabur Product
Table 107. Dabur Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 108. Dabur Recent Development
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Product
Table 112. Johnson & Johnson Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 113. Johnson & Johnson Recent Development
Table 114. Reckitt Benckiser Company Details
Table 115. Reckitt Benckiser Business Overview
Table 116. Reckitt Benckiser Product
Table 117. Reckitt Benckiser Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 118. Reckitt Benckiser Recent Development
Table 119. Pfizer Business Overview
Table 120. Pfizer Product
Table 121. Pfizer Company Details
Table 122. Pfizer Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 123. Pfizer Recent Development
Table 124. Sun Pharmaceutical Company Details
Table 125. Sun Pharmaceutical Business Overview
Table 126. Sun Pharmaceutical Product
Table 127. Sun Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 128. Sun Pharmaceutical Recent Development
Table 129. Novartis Company Details
Table 130. Novartis Business Overview
Table 131. Novartis Product
Table 132. Novartis Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 133. Novartis Recent Development
Table 134. Prestige Brands Company Details
Table 135. Prestige Brands Business Overview
Table 136. Prestige Brands Product
Table 137. Prestige Brands Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 138. Prestige Brands Recent Development
Table 139. Procter & Gamble Company Details
Table 140. Procter & Gamble Business Overview
Table 141. Procter & Gamble Product
Table 142. Procter & Gamble Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 143. Procter & Gamble Recent Development
Table 144. Toray Industries Company Details
Table 145. Toray Industries Business Overview
Table 146. Toray Industries Product
Table 147. Toray Industries Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 148. Toray Industries Recent Development
Table 149. Beijing Tongrentang Company Details
Table 150. Beijing Tongrentang Business Overview
Table 151. Beijing Tongrentang Product
Table 152. Beijing Tongrentang Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 153. Beijing Tongrentang Recent Development
Table 154. Essence Pharmaceutical Group Company Details
Table 155. Essence Pharmaceutical Group Business Overview
Table 156. Essence Pharmaceutical Group Product
Table 157. Essence Pharmaceutical Group Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 158. Essence Pharmaceutical Group Recent Development
Table 159. Jiangxi Heying Pharmaceutical Company Details
Table 160. Jiangxi Heying Pharmaceutical Business Overview
Table 161. Jiangxi Heying Pharmaceutical Product
Table 162. Jiangxi Heying Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 163. Jiangxi Heying Pharmaceutical Recent Development
Table 164. Diao Group Chengdu Pharmaceutical Company Details
Table 165. Diao Group Chengdu Pharmaceutical Business Overview
Table 166. Diao Group Chengdu Pharmaceutical Product
Table 167. Diao Group Chengdu Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 168. Diao Group Chengdu Pharmaceutical Recent Development
Table 169. Shanghai Pharmaceutical Company Details
Table 170. Shanghai Pharmaceutical Business Overview
Table 171. Shanghai Pharmaceutical Product
Table 172. Shanghai Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 173. Shanghai Pharmaceutical Recent Development
Table 174. Harbin Children's Pharmaceutical Company Details
Table 175. Harbin Children's Pharmaceutical Business Overview
Table 176. Harbin Children's Pharmaceutical Product
Table 177. Harbin Children's Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 178. Harbin Children's Pharmaceutical Recent Development
Table 179. China Resources Sanjiu Pharmaceutical Company Details
Table 180. China Resources Sanjiu Pharmaceutical Business Overview
Table 181. China Resources Sanjiu Pharmaceutical Product
Table 182. China Resources Sanjiu Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 183. China Resources Sanjiu Pharmaceutical Recent Development
Table 184. Xinjiang Quanan Pharmaceutical Company Details
Table 185. Xinjiang Quanan Pharmaceutical Business Overview
Table 186. Xinjiang Quanan Pharmaceutical Product
Table 187. Xinjiang Quanan Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 188. Xinjiang Quanan Pharmaceutical Recent Development
Table 189. Jiangsu Huayang Pharmaceutical Company Details
Table 190. Jiangsu Huayang Pharmaceutical Business Overview
Table 191. Jiangsu Huayang Pharmaceutical Product
Table 192. Jiangsu Huayang Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 193. Jiangsu Huayang Pharmaceutical Recent Development
Table 194. Nanjing Chengong Pharmaceutical Company Details
Table 195. Nanjing Chengong Pharmaceutical Business Overview
Table 196. Nanjing Chengong Pharmaceutical Product
Table 197. Nanjing Chengong Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 198. Nanjing Chengong Pharmaceutical Recent Development
Table 199. Beijing Jiulong Pharmaceutical Company Details
Table 200. Beijing Jiulong Pharmaceutical Business Overview
Table 201. Beijing Jiulong Pharmaceutical Product
Table 202. Beijing Jiulong Pharmaceutical Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 203. Beijing Jiulong Pharmaceutical Recent Development
Table 204. Livzon Group Company Details
Table 205. Livzon Group Business Overview
Table 206. Livzon Group Product
Table 207. Livzon Group Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 208. Livzon Group Recent Development
Table 209. Sinopharm Group Company Details
Table 210. Sinopharm Group Business Overview
Table 211. Sinopharm Group Product
Table 212. Sinopharm Group Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 213. Sinopharm Group Recent Development
Table 214. CSPC Company Details
Table 215. CSPC Business Overview
Table 216. CSPC Product
Table 217. CSPC Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 218. CSPC Recent Development
Table 219. Perrigo Company Company Details
Table 220. Perrigo Company Business Overview
Table 221. Perrigo Company Product
Table 222. Perrigo Company Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 223. Perrigo Company Recent Development
Table 224. Vernalis Company Details
Table 225. Vernalis Business Overview
Table 226. Vernalis Product
Table 227. Vernalis Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 228. Vernalis Recent Development
Table 229. Tris Pharma Company Details
Table 230. Tris Pharma Business Overview
Table 231. Tris Pharma Product
Table 232. Tris Pharma Revenue in Cough and Cold Preparations Business (2015-2020) (Million US$)
Table 233. Tris Pharma Recent Development
T
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs